Screening for primary aldosteronism in all hypertensive patients: inevitable strategy

Abstract:

Primary hyperaldosteronism (PA) accounts for 5%to 10%of all hypertensive patients. Screening is the first step of the diagnostic process of PA. Based on the latest evidences both at home and abroad, this manuscript puts forward the existing problems of screening and gives suggestions, in order to guide clinical work and improve the detection rate of PA.